Allspring Global Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,827
| Closed | -$20K | – | 2427 |
|
|
2023
Q4 | $20K | Sell |
3,827
-187,808
| -98% | -$982K | ﹤0.01% | 1958 |
|
|
2023
Q3 | $3.02M | Buy |
191,635
+20,204
| +12% | +$319K | 0.01% | 1090 |
|
|
2023
Q2 | $3.33M | Sell |
171,431
-50,999
| -23% | -$991K | 0.01% | 1096 |
|
|
2023
Q1 | $6.31M | Buy |
222,430
+71,802
| +48% | +$2.04M | 0.01% | 933 |
|
|
2022
Q4 | $4.4M | Buy |
150,628
+62,456
| +71% | +$1.83M | 0.01% | 1006 |
|
|
2022
Q3 | $2.33M | Sell |
88,172
-119,997
| -58% | -$3.17M | ﹤0.01% | 1194 |
|
|
2022
Q2 | $9.25M | Sell |
208,169
-43,810
| -17% | -$1.95M | 0.02% | 796 |
|
|
2022
Q1 | $12.5M | Sell |
251,979
-23,326
| -8% | -$1.15M | 0.02% | 812 |
|
|
2021
Q4 | $14M | Buy |
+275,305
| New | +$14M | 0.02% | 823 |
|